Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Hvidovre – page 56

1 426 clinical trials in Hvidovre, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Hvidovre at a glance
1 426
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 426 trials in Hvidovre

Open in trial search

Granulomatosis with polyangiitis

Not yet recruiting

Study of Empagliflozin, Losartan Potassium and Hydrochlorothiazide to Prevent Kidney Stones in Patients with Paraffin Oil Induced Granulomatous Disease

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Empagliflozin
  • Sponsor:Region Hovedstaden

Colon cancer

Not yet recruiting

Pembrolizumab for Patients with Localised dMMR Colon Cancer: Neoadjuvant and Organ-Sparing Treatment Study

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Region Sjaelland

Coma

Not yet recruiting

Study to evaluate the effect of methylphenidate hydrochloride on the time to wake up in patients in a coma due to acute brain injury

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Methylphenidate Hydrochloride
  • Sponsor:Region Hovedstaden

B precursor type acute leukaemia

Not yet recruiting

Study of asciminib, dexamethasone, blinatumomab, and vincristine sulfate in children and young adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Novartis Pharma AG

Iron deficiency

Not yet recruiting

Feasibility, Tolerability and Adherence of Alternate-Day Ferrous Sulfate (Duroferon) in Adolescent Girls With Iron Deficiency

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Ferrous Sulfate
  • Sponsor:Region Skane

Depression

Not yet recruiting

A study on the effects of support and music during psilocybin therapy for people with depression.

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Koebenhavns Universitet

Pulmonary fibrosis

Not yet recruiting

A study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Admilparant
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Glioblastoma

Not yet recruiting

Phase 3 Randomized Study of Niraparib Tosilate Monohydrate vs. Temozolomide in Newly Diagnosed MGMT Unmethylated Glioblastoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Neurotrials LLC

Infection

Not yet recruiting

Testing Personalized Drug Combination Treatment to Reduce Deaths in Patients with Severe Acute Infections

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acetylcysteine
  • Sponsor:Copenhagen University Hospital

Dermatitis atopic

Not yet recruiting

A Study of Lebrikizumab for Adults and Adolescents with Moderate to Severe Atopic Dermatitis to Evaluate Effects on Eczema and Skin Barrier Function

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Lebrikizumab
  • Sponsor:Region Oestergoetland

Chronic obstructive pulmonary disease

Not yet recruiting

Study of RSV vaccine and pneumococcal vaccine combination for patients aged 60 and older with chronic obstructive pulmonary disease

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Saline
  • Sponsor:Nordsjaellands Hospital

COVID-19

Not yet recruiting

Study of Intravenous Immunoglobulin Added to Standard Treatment for COVID-19 in Patients with Severely Weakened Immune System Due to B-cell Problems

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Nirmatrelvir
  • Sponsor:Region Vaesterbotten

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Hvidovre

What the registry says about research in the country

01 Infectious Disease Prevention

Research focusing on vaccine development and preventive measures against various infections, including studies on meningococcal vaccines for infants and Group B streptococcus prevention in pregnant women.

  • Meningococcal Infection Prevention
  • Streptococcal Disease Control
  • HIV Prevention Studies

Trials include evaluation of vaccine immunogenicity and safety profiles in different age groups.

02 Maternal and Women's Health

Innovative research addressing maternal mental health and pregnancy-related conditions, with studies focusing on postpartum depression prevention and maternal vaccination strategies.

  • Postpartum Depression Treatment
  • Pregnancy-Related Vaccinations
  • Caesarean Section Pain Management

Clinical investigations emphasize both maternal safety and infant outcomes.

03 Metabolic and Digestive Disorders

Comprehensive studies on inflammatory bowel diseases and metabolic conditions, including innovative treatments for obesity and diabetes management.

  • Crohn's Disease Therapies
  • Ulcerative Colitis Management
  • Weight Management Solutions

Trials evaluate both established and novel therapeutic approaches.

Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.